跳至主要内容
临床试验/CTRI/2023/08/056282
CTRI/2023/08/056282尚未招募3 期

Evaluation of efficacy of bhunimbadi churna vati in alcohol hepatitis - a single arm experimental study

Dr Amatullah Ataullah Dalvi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Able to provide written consent.
  • 2. Male or female patients between 22- 55 yrs of age.
  • 3. AST Value 50u/l to 400u/l
  • 4. Total bilirubin in the range of 2 mg/dl to 15mg/dl.
  • 5. AST:ALT > 1.5

排除标准

  • 1.Other liver pathology like viral hepatitis, drug induced hepatitis, non-alcoholic hepatitis,
  • immunocompromised patients.
  • 2.Patient with alcoholic withdrawal symptoms such as hallucination, abusive, agitated &
  • aggressive behavior.
  • 3. K/C/O - liver cirrhosis, liver cancer & ascites.
  • 4.K/C/O - renal disorder, cardiac disorder, hypertension and other chronic disorder, endocrinological
  • 5.K/C/O - Hemochromatosis, Wilson disease and other autoimmune disorder.
  • 6.Pregnant & lactating women.

研究者

发起方
Dr Amatullah Ataullah Dalvi

相似试验